NO904919L - Materiale for diagnostisering og behandling av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale. - Google Patents
Materiale for diagnostisering og behandling av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale.Info
- Publication number
- NO904919L NO904919L NO90904919A NO904919A NO904919L NO 904919 L NO904919 L NO 904919L NO 90904919 A NO90904919 A NO 90904919A NO 904919 A NO904919 A NO 904919A NO 904919 L NO904919 L NO 904919L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- diabetes mellitus
- insulin
- diagnostization
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Rehabilitation Therapy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO964483A NO304233B1 (no) | 1989-03-14 | 1996-10-22 | Polypeptid og sett for diagnostisering av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32286489A | 1989-03-14 | 1989-03-14 | |
US07/371,249 US5114844A (en) | 1989-03-14 | 1989-06-26 | Diagnosis and treatment of insulin dependent diabetes mellitus |
PCT/US1990/001397 WO1990010449A1 (en) | 1989-03-14 | 1990-03-14 | Diagnosis and treatment of insulin dependent diabetes mellitus |
Publications (3)
Publication Number | Publication Date |
---|---|
NO904919D0 NO904919D0 (no) | 1990-11-13 |
NO904919L true NO904919L (no) | 1991-01-14 |
NO300594B1 NO300594B1 (no) | 1997-06-23 |
Family
ID=26983648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO904919A NO300594B1 (no) | 1989-03-14 | 1990-11-13 | Analogifremgangsmåte for fremstilling av polypeptid og fremgangsmåte for fremstilling av T-celler med spesifisitet mot polypeptidet |
Country Status (10)
Country | Link |
---|---|
US (2) | US5114844A (no) |
EP (1) | EP0417271B1 (no) |
JP (3) | JP3165148B2 (no) |
AT (1) | ATE174689T1 (no) |
AU (1) | AU639456B2 (no) |
CA (1) | CA2029861C (no) |
DE (1) | DE69032833T2 (no) |
FI (1) | FI103976B (no) |
NO (1) | NO300594B1 (no) |
WO (1) | WO1990010449A1 (no) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001360A (en) * | 1988-12-13 | 1999-12-14 | University Of Florida | Method and compositions for early detection and treatment of insulin dependent diabetes mellitus |
US5645998A (en) | 1988-12-13 | 1997-07-08 | University Of Florida Research Foundation | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
US5762937A (en) * | 1988-12-13 | 1998-06-09 | University Of Florida Research Foundation, Inc. | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
US5780034A (en) * | 1989-03-14 | 1998-07-14 | Yeda Research And Development Co. Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents |
US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
US5427940A (en) * | 1991-06-03 | 1995-06-27 | Board Of Regents, The University Of Texas System | Engineered cells producing insulin in response to glucose |
GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
ES2223039T3 (es) * | 1990-09-07 | 2005-02-16 | The Regents Of The University Of California | Metodos para la diagnosis y tratamiento de diabetes. |
US5512447A (en) * | 1990-09-07 | 1996-04-30 | The Regents Of The University Of California | Methods for the diagnosis and treatment of diabetes |
US5674978A (en) * | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
US5998366A (en) * | 1990-09-21 | 1999-12-07 | The Regents Of The University Of California | Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders |
US5620686A (en) * | 1990-09-28 | 1997-04-15 | British Technology Group Limited | Antigen-antibody conjugates |
CA2096975C (en) * | 1990-11-26 | 2003-04-22 | Carl Wu | Cell stress transcriptional factors |
US6174862B1 (en) * | 1991-04-22 | 2001-01-16 | Ramot University Authority For Applied Research And Industrial Development, Ltd. | Neurotrophic peptides of activity dependent neurotrophic factor |
WO1992018140A1 (en) * | 1991-04-22 | 1992-10-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Activity-dependent neurotrophic factor |
JPH06508030A (ja) * | 1991-05-15 | 1994-09-14 | ザイモジェネティクス,インコーポレイティド | ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現 |
AU675416B2 (en) * | 1991-11-01 | 1997-02-06 | Joslin Diabetes Center | Antigen associated with type I diabetes mellitus |
AT398495B (de) * | 1992-06-09 | 1994-12-27 | Wick Georg Dr | Diagnose oder vorhersage von atherosklerose |
IL102687A (en) * | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
WO1994003478A1 (en) * | 1992-07-31 | 1994-02-17 | Immulogic Pharmaceutical Corporation | Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen |
US5420108A (en) * | 1992-09-14 | 1995-05-30 | Shohet; Isaac H. | Method of controlling diabetes mellitus |
US5872094A (en) * | 1993-01-06 | 1999-02-16 | The General Hospital Corporation | Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface |
CA2164298A1 (en) * | 1993-06-04 | 1994-12-22 | Richard A. Young | Stress proteins and uses therefor |
US5728385A (en) | 1993-08-12 | 1998-03-17 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
US7008790B1 (en) | 1993-08-12 | 2006-03-07 | Classen Immunotherapies, Inc. | Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae |
DE69435138D1 (de) * | 1993-11-23 | 2008-10-23 | Univ California | Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung |
US7300660B2 (en) | 1993-11-23 | 2007-11-27 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
US6752993B1 (en) | 1993-11-23 | 2004-06-22 | The Regents Of The University Of California | Abundant extracellular product vaccines and methods for their production and use |
US5863742A (en) * | 1994-03-10 | 1999-01-26 | Chiron Diagnostics Corporation | Inhibition of protease activity of human whole blood cell lysates |
DK0751957T3 (da) * | 1994-03-21 | 2004-06-01 | Univ Utrecht | Peptid-fragmenter af mikrobielle stressproteiner og farmaceutisk sammensætning fremstillet deraf til behandling og forebyggelse af inflammatoriske sygdomme |
US5869058A (en) * | 1994-05-25 | 1999-02-09 | Yeda Research And Development Co. Ltd. | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
WO1996001846A1 (en) * | 1994-07-08 | 1996-01-25 | Trustees Of Dartmouth College | Proinsulin peptide compounds for detecting and treating type i diabetes |
US6509165B1 (en) | 1994-07-08 | 2003-01-21 | Trustees Of Dartmouth College | Detection methods for type I diabetes |
WO1996005223A1 (en) * | 1994-08-12 | 1996-02-22 | The Regents Of The University Of California | Abundant extracellular products and methods for their production and use |
GB9419553D0 (en) * | 1994-09-27 | 1994-11-16 | Univ Bristol | Polypeptides and their use in the treatment of auto-immune disease |
MX9704738A (es) * | 1994-12-21 | 1997-10-31 | Yenda Res And Dev Co Ltd | Analogos de peptido p277 y composiciones farmaceuticas que los contienen, metodo de diagnostico de diabetes mellitus dependiente de la insulina y uso de los mismos. |
US6180103B1 (en) | 1994-12-21 | 2001-01-30 | Yeda Research And Development Co., Ltd. | Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
IL114407A0 (en) * | 1995-06-30 | 1995-10-31 | Yeda Res & Dev | Novel peptides and pharmaceutical compositions comprising them |
US20030190323A1 (en) * | 1995-07-05 | 2003-10-09 | Yeda Research And Development Co. Ltd. | Preparations and methods for the treatment of T cell mediated diseases |
US6488933B2 (en) | 1995-07-05 | 2002-12-03 | Yeda Research And Development Co. Ltd. | Preparations for the treatment of T cell mediated diseases |
IL114458A0 (en) * | 1995-07-05 | 1995-11-27 | Yeda Res & Dev | Therapeutic preparations for treatment of T cell mediated diseases |
US6013660A (en) * | 1996-10-02 | 2000-01-11 | The Regents Of The University Of California | Externally targeted prophylactic and chemotherapeutic method and agents |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
CA2282426A1 (en) * | 1997-02-18 | 1998-08-20 | The Whitehead Institute For Biomedical Research | Use of heat shock proteins to deliver moieties into cells |
CN100489105C (zh) * | 1997-08-05 | 2009-05-20 | 恩温塔生物制药学公司 | 包含hpv抗原和应激蛋白或者其表达载体的组合物激发的抗hpv抗原免疫应答 |
US20020009448A1 (en) * | 1997-09-19 | 2002-01-24 | Leslie P. Weiner | T-cell vaccination for the treatment of multiple sclerosis |
AU2566799A (en) * | 1998-01-27 | 1999-08-09 | Jane Pei-Fan Bai | Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same |
IL142709A0 (en) * | 1998-11-05 | 2002-03-10 | Hadasit Med Res Service | Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
US8158125B2 (en) * | 1998-11-05 | 2012-04-17 | Hadasit Medical Research Services & Development Ltd. | B-cell epitope peptides of HSP 65, novel amino acid sequences, DNA encoding the amino acid sequences of said peptides, antibodies directed against said peptides and different uses thereof in the treatment of inflammatory and autoimmune diseases |
US7488476B2 (en) * | 1998-11-05 | 2009-02-10 | Hadasit Medical Research Services & Development Ltd. | B-cell epitope peptides of HSP 65, DNA encoding said peptides, antibodies directed against said peptides and the different uses thereof in the treatment of inflammatory and autoimmune diseases |
US6497880B1 (en) * | 1998-12-08 | 2002-12-24 | Stressgen Biotechnologies Corporation | Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus |
JP2003504074A (ja) * | 1999-07-08 | 2003-02-04 | ストレスゲン バイオテクノロジーズ コーポレイション | インビトロでのTh1様応答の誘導 |
IL150113A0 (en) * | 1999-12-15 | 2002-12-01 | Peptor Ltd | Fragments and antagonists of heat shock protein 60 |
CA2396384A1 (en) | 2000-01-14 | 2001-07-19 | Whitehead Institute For Biomedical Research | In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
PL359930A1 (en) * | 2000-06-26 | 2004-09-06 | Stressgen Biotechnologies Corporation | Human papilloma virus treatment |
IL137460A0 (en) | 2000-07-24 | 2001-07-24 | Yeda Res & Dev | Identifying antigen clusters for monitoring a global state of an immune system |
CN1264572C (zh) | 2001-02-05 | 2006-07-19 | 斯特雷斯根生物技术公司 | 治疗hbv的融合蛋白及其应用 |
ES2526822T3 (es) * | 2002-01-31 | 2015-01-15 | Andromeda Bio Tech Ltd. | Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno |
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
EP1718158B1 (en) * | 2004-01-28 | 2014-07-02 | Andromeda Bio Tech Ltd. | Hsp therapy in conjunction with a low antigenicity diet |
US20050260770A1 (en) * | 2004-04-01 | 2005-11-24 | Cohen Irun R | Antigen array and diagnostic uses thereof |
US8691772B2 (en) | 2005-01-04 | 2014-04-08 | Yeda Research And Development Co. Ltd. | HSP60, HSP60 peptides and T cell vaccines for immunomodulation |
ES2389849T3 (es) | 2005-03-14 | 2012-11-02 | Yeda Research And Development Co., Ltd. | Ccomposiciones de péptidos HSP60 y antígenos víricos para vacunación y diagnóstico |
CA2658678A1 (en) | 2005-08-06 | 2007-02-15 | Gerald J. Prud'homme | Composition and method for prevention and treatment of type i diabetes |
EP2007427A4 (en) | 2006-04-11 | 2012-04-04 | Yeda Res & Dev | IMPROVED VACCINES COMPRISING PEPTIDE MULTIPLE MEDIA DERIVED FROM HSP60 |
DE102006019127A1 (de) * | 2006-04-25 | 2007-10-31 | Carl Zeiss Meditec Ag | Multiwellenlängen-Lasersystem und Verfahren für ophthalmologische Anwendungen |
WO2009090650A2 (en) | 2008-01-16 | 2009-07-23 | Ben-Gurion University Of The Negev Research And Development Authority | Vaccine for alzheimer's disease |
WO2013128453A1 (en) | 2012-03-01 | 2013-09-06 | Yeda Research And Development Co. Ltd. | Regeneration of islet beta cells by hsp60 derived peptides |
AU2013227249A1 (en) | 2012-03-01 | 2014-09-11 | Yeda Research And Development Co. Ltd. | Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes |
EP3090064B1 (en) | 2013-12-31 | 2019-11-13 | Yeda Research and Development Co. Ltd. | Diagnosis of systemic lupus erythematosus using oligonucleotides antigens |
CN107533058A (zh) | 2015-03-01 | 2018-01-02 | 免疫阵列有限公司 | 使用蛋白、肽和寡核苷酸抗原诊断***性红斑狼疮 |
KR101843000B1 (ko) * | 2016-12-07 | 2018-03-28 | 주식회사 에프앤디파트너스 | 피부 트러블별 미용 또는 치료 기능을 제공하는 개인 맞춤형 기능성 팩 및 그의 사용 방법 |
KR102292635B1 (ko) | 2019-07-26 | 2021-08-23 | (의)삼성의료재단 | 마스크 팩 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0261648B1 (en) * | 1986-09-23 | 1992-12-09 | Yeda Research And Development Company, Ltd. | Cell membrane proteins, compositions containing them and procedure for their preparation |
NL8701163A (nl) * | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
US4952395A (en) * | 1987-02-26 | 1990-08-28 | Scripps Clinic And Research Foundation | Mycobacterial recombinants and peptides |
NL8703107A (nl) * | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
IL85746A (en) * | 1988-03-15 | 1994-05-30 | Yeda Res & Dev | Preparations comprising t-lymphocyte cells treated with 8-methoxypsoralen or cell membranes separated therefrom for preventing or treating autoimmune diseases |
US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
-
1989
- 1989-06-26 US US07/371,249 patent/US5114844A/en not_active Expired - Lifetime
-
1990
- 1990-03-14 EP EP90908064A patent/EP0417271B1/en not_active Expired - Lifetime
- 1990-03-14 DE DE69032833T patent/DE69032833T2/de not_active Expired - Lifetime
- 1990-03-14 AT AT90908064T patent/ATE174689T1/de not_active IP Right Cessation
- 1990-03-14 CA CA002029861A patent/CA2029861C/en not_active Expired - Lifetime
- 1990-03-14 JP JP50811690A patent/JP3165148B2/ja not_active Expired - Fee Related
- 1990-03-14 AU AU55467/90A patent/AU639456B2/en not_active Expired
- 1990-03-14 WO PCT/US1990/001397 patent/WO1990010449A1/en active IP Right Grant
- 1990-11-13 NO NO904919A patent/NO300594B1/no not_active IP Right Cessation
- 1990-11-13 FI FI905614A patent/FI103976B/fi active IP Right Grant
-
1993
- 1993-03-29 US US08/039,704 patent/US5671848A/en not_active Expired - Lifetime
-
1999
- 1999-07-26 JP JP21116199A patent/JP3203323B2/ja not_active Expired - Lifetime
-
2000
- 2000-05-29 JP JP2000157825A patent/JP2001010962A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0417271A1 (en) | 1991-03-20 |
FI103976B1 (fi) | 1999-10-29 |
AU639456B2 (en) | 1993-07-29 |
EP0417271B1 (en) | 1998-12-16 |
US5671848A (en) | 1997-09-30 |
JP3203323B2 (ja) | 2001-08-27 |
JPH04502920A (ja) | 1992-05-28 |
NO904919D0 (no) | 1990-11-13 |
JP2000055916A (ja) | 2000-02-25 |
CA2029861C (en) | 2001-01-16 |
ATE174689T1 (de) | 1999-01-15 |
JP3165148B2 (ja) | 2001-05-14 |
AU5546790A (en) | 1990-10-09 |
EP0417271A4 (en) | 1992-09-09 |
FI905614A0 (fi) | 1990-11-13 |
US5114844A (en) | 1992-05-19 |
JP2001010962A (ja) | 2001-01-16 |
FI103976B (fi) | 1999-10-29 |
WO1990010449A1 (en) | 1990-09-20 |
DE69032833D1 (de) | 1999-01-28 |
CA2029861A1 (en) | 1990-09-15 |
NO300594B1 (no) | 1997-06-23 |
DE69032833T2 (de) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO904919D0 (no) | Materiale for diagnotisering og behandling av insulinavhengig diabetes mellitus samt fremstilling av slikt materiale | |
Rehfeld et al. | Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients | |
NZ217570A (en) | Antibody complexes of hapten modified diagnostic or therapeutic agents | |
IE890182L (en) | Cloned genes encoding IG-CD4 fusion proteins and the use thereof | |
ES2121915T3 (es) | Ligandos del receptor eck. | |
DK228190D0 (da) | Rajgraespollenallergen | |
ATE122394T1 (de) | Pankreatische isletzellen-antigene, erhalten durch molekulare klonierung. | |
ES2033823T3 (es) | Ensayo en cuanto a cancer de mama humano. | |
DE3887750D1 (de) | Selektive entfernung von immunkomplexen. | |
DE3750225D1 (de) | Herstellung und verwendung von anti-helminthischen wirkstoffen und schutzantigenen. | |
ATE114817T1 (de) | Immunologisches nachweisverfahren für herbizide. | |
Swedlund et al. | Comparison of certain properties of naturally occurring low molecular weight γM and the γM monomer derived by reduction and alkylation of 19 S γM | |
FR2563630B1 (fr) | Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux | |
AU3039589A (en) | Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor | |
Fraser et al. | Proteins retained with hyaluronic acid during ultrafiltration of synovial fluid | |
Devlin et al. | Preferential Beef/Pork Insulin-binding Capacity: Radioimmunoelectrophoretic and Chromatographic Data in Patients with Dermal Reactions to Insulin | |
Kinet et al. | Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Evidence for a protein A leaking by radioimmunoassay | |
Nielsen et al. | Non-respiratory haemolymph proteins in the vineyard snail Helix pomatia. Changes after phagocytosis in vivo | |
Veltri et al. | Protein‐A antibody‐binding (PAAB) technique for detection of tumor‐associated membrane antigen (TAMA) of lewis lung carcinoma | |
DE3586795D1 (de) | Absorptionsverbesserer fuer proteine. | |
RU93007311A (ru) | Способ определения термостабильных и термолабильных противоящурных антител в сыворотке крови крупного рогатого скота | |
RU93020826A (ru) | Способ контроля патогенеза заболеваний, связанных с накоплением холестерина в мембранах эритроцитов | |
KR880013012A (ko) | 항-프리-s- 항체의 분석법 | |
PT85248A (fr) | Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants | |
Asensi et al. | Investigation of Yersinia enterocolitica in rheumatic human patients. II- Serology. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |